Concepedia

Adı́lia Hormigo

AH

Statistics

Publications

33

Citations

3.3K

H-Index

24

Active since

1990

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Memorial Sloan Kettering Cancer Center

University of California, Los Angeles

Cornell University

Tisch Hospital

Adı́lia Hormigo is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, neuro-oncology, and oncology.

ORCID

Top concepts

Publications per year

1990–2023

33

Publications

33

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

Sergey V. Shmelkov, Jason M. Butler, Andrea T. Hooper et al. · Journal of Clinical Investigation · 2008 · 889 citations · Full text

, , +14

Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice

Sergey V. Shmelkov, Adı́lia Hormigo, Deqiang Jing et al. · Nature Medicine · 2010 · 352 citations · Full text

, , +15

Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma

Igor T. Gavrilovic, Adı́lia Hormigo, Joachim Yahalom et al. · Journal of Clinical Oncology · 2006 · 319 citations

YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas

Adı́lia Hormigo, Bin Gu, Sasan Karimi et al. · Clinical Cancer Research · 2006 · 178 citations

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

Jennifer Clarke, Fábio M. Iwamoto, Joohee Sul et al. · Journal of Clinical Oncology · 2009 · 177 citations · Full text

1–5 of 33